Nike's China Weakness, Oracle's TikTok Deal, and FedEx Earnings: Stock Movers Report

Nike's Financial Performance

• 📉 Nike shares experienced a significant drop of approximately 10% in pre-market trading following disappointing third-quarter guidance.
• 🇨🇳 The company cited persistent weakness in China as a major factor, a surprising development after two consecutive quarters of sales growth.
• 👟 The Converse brand also emerged as a weak point, with sales plunging by 30% in the latest quarter.
• 📈 Nike's CEO described the company's rebound as being in its "middle innings," indicating a positive outlook for the future despite current challenges.

Oracle and TikTok Partnership

• 🚀 Oracle shares saw a substantial increase, rising by nearly 5% in pre-market trade.
• 🤝 This rally is attributed to TikTok's announcement of a long-delayed plan to separate from its Chinese parent, ByteDance, with Oracle leading a group of buyers.
• 🇺🇸 Binding agreements have been signed to establish a US joint venture, majority-owned by American investors, which will manage data protection, content moderation, and algorithms.
• 💰 The potential valuation of the deal was previously flagged around $14 billion, and the market appears to be reacting positively to Oracle's significant stake.

FedEx Earnings and Outlook

• 📦 FedEx shares edged lower, down just under 1%, as investors digest the company's latest earnings report.
• ✈️ A string of cost headwinds, including the grounding of some MD-11 planes, impacted the previous quarter's results.
• 🛠️ While FedEx is undergoing a sweeping network overhaul and efforts to reduce structural costs, the market is eager to see significant improvements in profitability sooner rather than later.

Pharmaceutical Sector News

• 💊 Reports suggest that drug makers, including Abby, Bristol Myers, Gilead, and Merck, are expected to announce agreements with the US to lower certain prescription drug prices.
• 📉 Several of these pharmaceutical stocks traded softly in US pre-market, with Gilead, Merck, and Abby showing slight declines.
• 🌍 This development follows a series of more positive reports regarding European drug makers reaching agreements with the US, easing tensions around prescription drug pricing.